Role of Oxidative Stress in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma

• Main Authors: Yasemin Aydın Yaz, Nilgün Yıldırım, Yetkin Yaz, Neslihan Tekin, Mine İnal, Fezan Mutlu Şahin
• Format: Article
• Language: English
• Published: Galenos Yayinevi 2019-04-01
• Series: Türk Oftalmoloji Dergisi
• Subjects: Pseudoexfoliation; glaucoma; oxidative stress
• Online Access: http://www.oftalmoloji.org/archives/archive-detail/article-preview/role-of-oxidative-stress-in-pseudoexfoliation-synd/27413
• ISSN: 1300-0659; 2147-2661

Objectives:To investigate the role of oxidative stress on pseudoexfoliation formation and progression from pseudoexfoliation syndrome (XFS) to pseudoexfoliation glaucoma (XFG).Materials and Methods:This study investigated oxidative stress biomarkers in blood samples from 58 patients with XFG, 47 patients with XFS, and 134 healthy age- and sex-matched controls.Results:The highest serum malondialdehyde (MDA) levels were measured in XFG patients (p<0.001), and MDA level was higher in XFS patients than controls (p<0.001). Superoxide dismutase (SOD) and catalase (CAT) enzyme activities were significantly lower in XFS and XFG patients than in the control group, whereas a significant increase was observed in glutathione (GSH) levels (p<0.001 for all). However, levels of these three biomarkers did not differ significantly between XFS and XFG patients (p=0.188, p=0.185, and p=0.733, respectively). Nitric oxide (NO) concentration was significantly lower in XFG patients compared to XFS patients and controls (p<0.001) but did not differ between XFS patients and controls (p=0.476).Conclusion:Elevated MDA levels suggest that lipid peroxidation is important in XFS and XFG development and progression from XFS to XFG. In addition, reduction in SOD and CAT enzyme activities is considered a deficiency in the enzymatic antioxidant protection system. Furthermore, GSH values may be evaluated as a compensatory response to oxidative stress in XFS and XFG. Alterations in NO indicate the role of a vascular regulatory factor in the progression from XFS to glaucoma.